Assessment of the mode of action for hexavalent chromium-induced lung cancer following inhalation exposures.
Proctor DM, Suh M, Campleman SL, Thompson CM.
Toxicology. 2014 Nov 5;325:160-79. doi: 10.1016/j.tox.2014.08.009. Epub 2014 Aug 28.
PMID:25174529
Burden of lung cancer and predicted costs of occupational exposure to hexavalent chromium in the EU - The impact of different occupational exposure limits.
Chen-Xu J, Jakobsen LS, Pires SM, Viegas S.
Environ Res. 2023 Jul 1;228:115797. doi: 10.1016/j.envres.2023.115797. Epub 2023 Mar 29.
PMID:37001847
HK2 and LDHA upregulation mediate hexavalent chromium-induced carcinogenesis, cancer development and prognosis through miR-218 inhibition.
Wang L, Zhang RK, Sang P, Xie YX, Zhang Y, Zhou ZH, Wang KK, Zhou FM, Ji XB, Liu WJ, Qiu JG, Jiang BH.
Ecotoxicol Environ Saf. 2024 Jul 1;279:116500. doi: 10.1016/j.ecoenv.2024.116500. Epub 2024 May 24.
PMID:38795416
Chronic Hexavalent Chromium Exposure Upregulates the RNA Methyltransferase METTL3 Expression to Promote Cell Transformation, Cancer Stem Cell-Like Property, and Tumorigenesis.
Wang Z, Uddin MB, Xie J, Tao H, Zeidler-Erdely PC, Kondo K, Yang C.